Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology
Salvador Bello(Servicio Aragonés de Salud), Antoní Torres(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Sergio Fandos(Neumont University), Rosario Menéndez(Hospital Universitari i Politècnic La Fe), Maria Angeles Ruiz(Hospital Universitario Miguel Servet), Francisco De Pablo(Neumont University), Elisa Mincholé(Neumont University), Ana Lasierra(Hospital Universitario Miguel Servet), Elisabeth Vera(Neumont University), Miguel D. Ferrer(Universidad de Zaragoza)
Cited by 124
Related Papers
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
|European Respiratory Journal|2017|1.4k
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study
|Intensive Care Medicine|2021|421
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
|Intensive Care Medicine|2023|289
Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases
|Current Medicinal Chemistry|2018|242